Simple blood test could spot Alzheimer's years early in hong kong seniors
NCT ID NCT07347574
First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study will follow 2,500 elderly people in Hong Kong for 2-3 years to find early signs of Alzheimer's disease. Researchers will use blood tests, brain scans, and memory assessments to see if a simple blood test can detect the disease before symptoms get worse. The goal is to create a less invasive and cheaper way to screen for Alzheimer's in the community.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test for early Alzheimer's detection in Chinese populations, enabling earlier intervention.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find reliable biomarkers, and results may not apply to other ethnic groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AD - ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hong Kong University of Science and Technology
RECRUITINGHong Kong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your brain help unlock Alzheimer's secrets?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Could sharing lived experiences ease the burden of dementia care?
- A new tool aims to shield dementia patients from neglect